免疫系统
肿瘤微环境
免疫疗法
调节器
黑色素瘤
免疫逃逸
主调节器
生物
癌症研究
免疫学
免疫检查点
免疫监视
医学
PD-L1
机制(生物学)
计算生物学
肿瘤细胞
CTLA-4号机组
免疫
T细胞
癌症免疫疗法
作者
Rachel M. Hurley,Hesham Mohei,Malay Haldar
出处
期刊:Annual Review of Pathology-mechanisms of Disease
[Annual Reviews]
日期:2026-10-14
标识
DOI:10.1146/annurev-pathmechdis-042624-121246
摘要
The tumor immune microenvironment (TIME) has emerged as a crucial regulator of antitumor immune responses with important therapeutic, prognostic, and predictive implications. Despite the success of immunotherapies in select solid tumors, notably melanoma and non-small cell lung cancer, their impact in soft-tissue sarcomas (STSs) is limited, often attributed to an immune-cold TIME passively driven by low neoantigen burden. Herein, we review the current understanding of the STS TIME, its variability across STS subtypes, and its implications for STS immunotherapy. We propose that the prevailing view of STSs as passively immune-cold is incomplete and that active tumor-driven immune suppression is likely underappreciated. Distinguishing active from passive immune escape and understanding its mechanistic underpinnings will be important to rationally design effective TIME-targeted therapies in STSs and to serve as a paradigm for therapeutic interventions in other immune-cold tumors.
科研通智能强力驱动
Strongly Powered by AbleSci AI